Skip to content
← Full study record

NCT02793544 · OUTCOME

Donor Selection Characteristics: Donor Weight

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide · Source last updated 2025-08-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
kg
Interval / dispersion
Full Range
Time frame
Pre-HCT

What was measured

Donor weight

Groups in this outcome

Myeloablative Conditioning (MAC)

Participants received one of three regimens: cyclophosphamide and total body irradiation; busulfan and cyclophosphamide; or fludarabine and busulfan

Reduced Intensity Conditioning (RIC)

Participants received one of two regimens: fludarabine, cyclophosphamide, and low-dose total body irradiation

Total

Total number of participants

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Myeloablative Conditioning (MAC)40
Reduced Intensity Conditioning (RIC)40
Total80

Reported measurements

Source class 1
Values in kg · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Myeloablative Conditioning (MAC)77Not reported55103Not reported
Reduced Intensity Conditioning (RIC)77Not reported52104Not reported
Total77Not reported52104Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        55
        upper Limit
        103
        value
        77
      2. group Id
        OG001
        lower Limit
        52
        upper Limit
        104
        value
        77
      3. group Id
        OG002
        lower Limit
        52
        upper Limit
        104
        value
        77
denoms
  1. counts
    1. group Id
      OG000
      value
      40
    2. group Id
      OG001
      value
      40
    3. group Id
      OG002
      value
      80
    units
    Participants
description
Donor weight
dispersion Type
Full Range
groups
  1. description
    Participants received one of three regimens: cyclophosphamide and total body irradiation; busulfan and cyclophosphamide; or fludarabine and busulfan
    id
    OG000
    title
    Myeloablative Conditioning (MAC)
  2. description
    Participants received one of two regimens: fludarabine, cyclophosphamide, and low-dose total body irradiation
    id
    OG001
    title
    Reduced Intensity Conditioning (RIC)
  3. description
    Total number of participants
    id
    OG002
    title
    Total
param Type
MEDIAN
reporting Status
POSTED
time Frame
Pre-HCT
title
Donor Selection Characteristics: Donor Weight
type
SECONDARY
unit Of Measure
kg

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice